ReviewNature reviews. Urology2012
The emerging role of diffusion-weighted MRI in prostate cancer management.
Review in Nature reviews. Urology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Partial Fourier in the presence of respiratory motion in prostate diffusion-weighted echo planar imaging.Magma (New York, N.Y.) · 2024Article
- VERDICT MRI validation in fresh and fixed prostate specimens using patient-specific moulds for histological and MR alignment.NMR in biomedicine · 2019Article
- Multicenter Repeatability Study of a Novel Quantitative Diffusion Kurtosis Imaging Phantom.Tomography (Ann Arbor, Mich.) · 2019Article
- The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study.BMC medicine · 2018Article
- Genes involved in prostate cancer progression determine MRI visibility.Theranostics · 2018Article
- Novel concepts for risk stratification in prostate cancer.Journal of clinical urology · 2016Article
- Evaluation of the 2015 Gleason Grade Groups in a Nationwide Population-based Cohort.European urology · 2016Article
- Prospective Pilot Trial to Evaluate a High Resolution Diffusion-Weighted MRI in Prostate Cancer Patients.EBioMedicine · 2016Article
- Targeted transperineal biopsy of the prostate has limited additional benefit over background cores for larger MRI-identified tumors.World journal of urology · 2016Article
- Article
- Seminal plasma as a diagnostic fluid for male reproductive system disorders.Nature reviews. Urology · 2014Review
- The role of MRI in prostate cancer active surveillance.BioMed research international · 2014Review
- Changing presentation of prostate cancer in a UK population--10 year trends in prostate cancer risk profiles in the East of England.British journal of cancer · 2013Article
- Controversies on individualized prostate cancer care: gaps in current practice.Therapeutic advances in urology · 2013Article
- Functional and molecular imaging: applications for diagnosis and staging of localised prostate cancer.Clinical oncology (Royal College of Radiologists (Great Britain)) · 2013Review
- Nanoparticle PET/CT imaging of natriuretic peptide clearance receptor in prostate cancer.Bioconjugate chemistry · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
A significant amount of research has focused on the role of diffusion-weighted MRI (DW-MRI) in the management of patients with prostate cancer. Although uncertainties remain, a clearer picture of where this technique fits into clinical practice is now available. A combination of DW-MRI and T2-weighted MRI (T2W-MRI) demonstrates improved accuracy for lesion detection and localization compared with T2W-MRI alone, and has been suggested as a tool to guide tissue biopsy. DW-MRI could also have roles in active surveillance, evaluating treatment efficacy, and predicting disease recurrence. Furthermore, DW-MRI offers the exciting possibility of gathering information about tumor characteristics and aggressiveness in a noninvasive manner. Validation in large prospective multicenter trials is critical if this technique is to be integrated into current management algorithms for prostate cancer.
Indexed as
Identifiers
22249194What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.